FDA Investigation Unlikely to Influence Biogen's (BIIB) Aduhelm Uptake - Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. TSLA

Go back to FDA Investigation Unlikely to Influence Biogen's (BIIB) Aduhelm Uptake - Analyst
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 200.05 +0.09 (0.05%)
Previous Close $199.96    52 Week High $333.65 
Open $200.57    52 Week Low $223.02 
Day High $203.45    P/E 25.61 
Day Low $199.06    EPS $7.81 
Volume 837,294